本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

17.64
-0.0800-0.45%
盘前17.34-0.3000-1.70%04:30 EDT
成交量:166.21万
成交额:2,940.34万
市值:22.55亿
市盈率:102.32
高:17.98
开:17.62
低:17.48
收:17.72
52周最高:30.48
52周最低:16.10
股本:1.28亿
流通股本:7,811.99万
量比:0.54
换手率:2.13%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
净资产收益率:7.48%
总资产收益率:3.53%
市净率:6.09
市盈率(LYR):102.32

数据加载中...

2025/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/01

重要事件披露

Form 8-K - Current report
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/21

重要事件披露

Form 8-K - Current report
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities